Skip to main content
. 2019 Jun 26;12:161. doi: 10.1186/s13068-019-1502-z

Table 4.

Effects of enzymatic pretreatments in crystallinity and physical properties of the films obtained after mechanical fibrillation

Crystallinity (%) Transparency (%) Density (g cm−3) Bekk smoothness (s)
Upper face Lower face Upper face
R 89.1 ± 0.1 27.8 ± 0.9 28.0 ± 0.1 0.8 ± 0.1 15 ± 4
Ck 88.5 ± 0.5 35.9 ± 3.7 36.0 ± 3.7 0.8 ± 0.1 10 ± 1
C9 90.3 ± 0.2 54.3 ± 0.4 52.9 ± 0.2 1.0 ± 0.1 29 ± 5
C50 91.4 ± 0.1 83.4 ± 0.5 83.2 ± 1.1 1.1 ± 0.0 46 ± 6
CF 91.0 ± 0.3 74.9 ± 0.7 73.8 ± 0.5 1.1 ± 0.1 53 ± 2
Cll 91.4 ± 0.2 75.7 ± 0.9 74.7 ± 0.8 1.1 ± 0.0 34 ± 2
Cmix 92.4 ± 0.2 86.1 ± 0.5 85.9 ± 1.5 0.9 ± 0.0 50 ± 6
Sk 89.0 ± 0.2 52.9 ± 1.8 51.5 ± 2.3 0.8 ± 0.1 11 ± 2
S 90.5 ± 0.5 60.0 ± 0.4 60.9 ± 0.3 0.9 ± 0.0 10 ± 2
SCmix 92.5 ± 0.1 85.6 ± 0.5 85.3 ± 0.5 1.1 ± 0.1 53 ± 1
L_Tempo 89.8 ± 0.1 38.9 ± 3.2 37.8 ± 1.8 0.9 ± 0.1 14 ± 3
Com 81.1 ± 0.2 66.2 ± 0.7 66.7 ± 0.4 1.0 ± 0.0 19 ± 3

R (initial refined pulp), Ck (cellulase control treatment), C9 (Cel9B), C50 (Sertec20 cellulase), CF (Fibercare cellulase), Cll (Celluclast cellulase), Cmix (cellulase mixture consisting in Fibercare and Celluclast), Sk (LPMO control treatment), S (LPMO), SCmix (LPMO and Cmix), L_Tempo (Laccase_Tempo treatment) and Com (commercial NFC)